← Leaderboards
Chunling Yi
Wistar Institute
$5,757,665
Attributed
$6,790,715
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2006–25$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,790,715 · 6
By mechanism
R01$5,799,539 · 3
T32$444,859 · 1
R21$401,117 · 1
F32$145,200 · 1
Top collaborators
- Alessandro Gardini3 shared
- Anna Tate Riegel2 shared
- David J Robbins2 shared
Most similar at Wistar Institute
Same institution · by research overlap
- Alessandro Gardini$5,135,185
- Italo Tempera$10,539,492
- Jessie Villanueva$8,602,569
- Chengyu Liang$16,417,485
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsSignal TransductionTumorGenesOncogenicGenetic TranscriptionTranscription FactorIn VivoMutationTumor GrowthMolecularInsightComplexPathway InteractionsOncoproteinsNext GenerationTherapy ResistantProteinsGrantGeneticResistanceNeoplastic CellResponseLesion
Grant awards (21)
Mechanisms of Epigenetic Plasticity in PDAC$492,890
R01 · FY2025 · CA · contact PI
Strategies to Disrupt Oncogenic Transcription in RCC Tumors$356,850
R01 · FY2025 · CA · contact PI
Training Grant In Tumor Biology$112,003
T32 · FY2025 · CA · contact PI
Mechanisms of Epigenetic Plasticity in PDAC$468,246
R01 · FY2024 · CA · contact PI
Strategies to Disrupt Oncogenic Transcription in RCC Tumors$339,008
R01 · FY2024 · CA · contact PI
Training Grant In Tumor Biology$332,856
T32 · FY2024 · CA · contact PI
Mechanisms of Epigenetic Plasticity in PDAC$483,032
R01 · FY2023 · CA · contact PI
Strategies to Disrupt Oncogenic Transcription in RCC Tumors$349,713
R01 · FY2023 · CA · contact PI
Mechanisms of Epigenetic Plasticity in PDAC$483,032
R01 · FY2022 · CA · contact PI
Strategies to Disrupt Oncogenic Transcription in RCC Tumors$349,713
R01 · FY2022 · CA · contact PI
Mechanisms of Epigenetic Plasticity in PDAC$506,890
R01 · FY2021 · CA · contact PI
An Inducible Model for Studying Cancer Stem Cells in PDAC$401,117
R21 · FY2021 · CA · contact PI
Strategies to Disrupt Oncogenic Transcription in RCC Tumors$356,850
R01 · FY2021 · CA · contact PI
The Yap-Tead transcriptional complex in Kras-induced Pancreatic Ductal Adenocarci$322,663
R01 · FY2018 · CA · contact PI
The Yap-Tead transcriptional complex in Kras-induced Pancreatic Ductal Adenocarci$322,663
R01 · FY2017 · CA · contact PI
The Yap-Tead transcriptional complex in Kras-induced Pancreatic Ductal Adenocarci$322,663
R01 · FY2016 · CA · contact PI
The Yap-Tead transcriptional complex in Kras-induced Pancreatic Ductal Adenocarci$322,663
R01 · FY2015 · CA · contact PI
The Yap-Tead transcriptional complex in Kras-induced Pancreatic Ductal Adenocarci$322,663
R01 · FY2014 · CA · contact PI
Elucidation of NF2's tumor supressive function$50,428
F32 · FY2008 · CA · contact PI
Elucidation of NF2's tumor supressive function$48,796
F32 · FY2007 · CA · contact PI
Elucidation of NF2's tumor supressive function$45,976
F32 · FY2006 · CA · contact PI